spell
Ai jiao ku Hao
Laiyuan
It is the whole grass of dicotyledonous medicine absinthe.
work efficiency
Anti-inflammatory, heat-clearing and detoxicating.
Ruling; ruling
Treat otitis media, wind-fire eye, wind-fire toothache, stomatitis and pharyngolaryngitis.
Sexual taste orientation
Bitter and cold
Lung and stomach meridians
dosage
Oral administration: decoction, 2 ~ 3 yuan; Or sweat. External use: pouring juice, ear drops, eye drops, or grinding beams.
Another name
Japan is a medicine. , wormwood, Fritillaria cirrhosa (Yunnan selected Chinese herbal medicine), Gentiana scabra. (Sichuan Chinese herbal medicine newsletter)
Distribution of animal and plant resources
Distributed in Yunnan and Sichuan.
Collection and storage of medicinal materials
Autumn harvest.
Latin name
Erigeron buchner
Examination certificate
Common folk herbs in Kunming.
Chemical constituents of traditional Chinese medicine
The whole plant contains alkaloids, saponins, phenols, acidic substances and a small amount of volatile oil.
As the first choice for malaria treatment, artemisinin, a traditional Chinese medicine, is expected to become a "new force" against human blood system diseases. Recently, clinicians and basic medical experts of Harbin Medical University have conducted in-depth research and discussion on the effect and possible mechanism of artemisinin on human leukemia cell lines and primary cells, and found that artemisinin can promote leukemia cell apoptosis for the first time in China.
Artemisia annua is an annual herbal medicinal plant, also known as Artemisia annua, Artemisia absinthe and Artemisia annua, which is mostly used for clearing away heat and relieving summer heat and stopping malaria. In the mid-1960s, China researchers first extracted artemisinin with low toxicity, safety and high efficiency from this herb. Soon after it was put into use, it was widely recognized by the global medical community and was listed as the first choice for malaria treatment. In clinic, it quickly replaced the traditional old drugs such as quinine, and at the same time reduced the demand for cinchona cream and long-acting sulfanilamide in all countries of the world. Not only that, artemisinin has also achieved reliable curative effect on systemic lupus erythematosus and discoid lupus erythematosus.
Heilongjiang Key Laboratory of Biomedical Engineering, affiliated to Harbin Medical University, is one of the earliest scientific research units in China to study artemisinin. Yang Baofeng, Professor Zhou Jin and other scholars in our laboratory found that artemisinin can effectively inhibit the proliferation of solid tumor cells, thus deeply discussing the mechanism of artemisinin "killing" leukemia cells. The experimental results show that artemisinin can increase the intracellular calcium level of leukemia cells, leading to degeneration and necrosis of leukemia cells. It is found that leukemia cell membrane is the main target of artemisinin attack, and its anti-tumor mechanism includes "apoptosis" and "swelling death", which is the key to determine the death mode of leukemia tumor cells. Once the leukemia cell membrane is destroyed, its permeability will change, and a large number of calcium ions will enter the cell. First, it will cause programmed cell death, namely "apoptosis"; The second is to cause changes in intracellular osmotic pressure, absorb a lot of water, and make cells swell until they die, that is, "swelling".
Experts pointed out that the above research provided very important experimental evidence for the new use of artemisinin against leukemia; It is expected that artemisinin will further expand its indications and bring new light to many patients with "blood tumors".